Commercio CVAC

CureVac N.V.

-

00:00:00

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in TĆ¼bingen, Germany.
Leggi tutto...

CVAC
Specifiche commerciali

Cifre

3

Punto

0.001

Diffusione

floating

Dimensioni del contratto

1

Volume Min

1

Volume massimo

10,000

Volume Step

1

Scambio lungo (punti)

-2.270

Scambio breve (punti)

-1.310
Disponibile su
MT5, TV, cTrader
Ultimo aggiornamento a Dicembre 11, 21:09 GMT+3
*Fonte dei dati: Prezzi del conto MT5 Server Prime

CVAC
Calendario economico

Non sono stati trovati dati

Cambiamento 1D

1.911%

PerchƩ BlackBull Mercati?

26k+

AttivitĆ  negoziabili

1:500

Leva fino a

Regolamentato

Multiregolamentato

24/7

Assistenza clienti

$0

Nessun deposito minimo

Calcolatore del margine

Calculation Results

Current Price

3.26

Required Margin

Converted Currency

Required Margin

Account Base Currency

Calcolatore di profitti e perdite

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Calcolatore di swap

Calculation Results

3.26

OpportunitĆ  di trading

Non sono stati trovati dati
Join Now